Amfebutamone Hydrobromide Market Key Drivers and Forecast 2025-2032
Amfebutamone Hydrobromide Market Drivers And Trends The Amfebutamone Hydrobromide market was valued at USD 0.85 Billion in 2022 and is projected to reach USD 1.25 Billion by 2030, growing at a CAGR of 5.0% from 2024 to 2030. The increasing demand for advanced treatments for central nervous system disorders, including depression and smoking cessation, is […]
Continue Reading